China Medical System Stock Net Asset
| CHSYFDelisted Stock | USD 0.93 0.00 0.00% |
China Medical System fundamentals help investors to digest information that contributes to China Medical's financial success or failures. It also enables traders to predict the movement of China Pink Sheet. The fundamental analysis module provides a way to measure China Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China Medical pink sheet.
China |
China Medical System Company Net Asset Analysis
China Medical's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current China Medical Net Asset | 15.81 B |
Most of China Medical's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China Medical System is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, China Medical System has a Net Asset of 15.81 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The net asset for all United States stocks is notably lower than that of the firm.
China Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Medical's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of China Medical could also be used in its relative valuation, which is a method of valuing China Medical by comparing valuation metrics of similar companies.China Medical is currently under evaluation in net asset category among its peers.
China Fundamentals
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.36 % | |||
| Operating Margin | 0.37 % | |||
| Current Valuation | 3.84 B | |||
| Shares Outstanding | 2.45 B | |||
| Shares Owned By Insiders | 49.55 % | |||
| Shares Owned By Institutions | 19.25 % | |||
| Price To Earning | 8.10 X | |||
| Price To Book | 1.71 X | |||
| Price To Sales | 0.45 X | |||
| Revenue | 8.34 B | |||
| Gross Profit | 6.25 B | |||
| EBITDA | 3.48 B | |||
| Net Income | 3.02 B | |||
| Cash And Equivalents | 5.25 B | |||
| Cash Per Share | 2.14 X | |||
| Total Debt | 573.81 M | |||
| Debt To Equity | 0.13 % | |||
| Current Ratio | 3.16 X | |||
| Book Value Per Share | 5.64 X | |||
| Cash Flow From Operations | 2.49 B | |||
| Earnings Per Share | 0.19 X | |||
| Number Of Employees | 5.45 K | |||
| Beta | 0.82 | |||
| Market Capitalization | 4.19 B | |||
| Total Asset | 15.81 B | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.06 % | |||
| Net Asset | 15.81 B | |||
| Last Dividend Paid | 0.52 |
About China Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Medical System's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Medical System based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in China Pink Sheet
If you are still planning to invest in China Medical System check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Medical's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |